Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07108608 · ClinicalTrials.gov registry record · NA
Adaptation of Written Exposure Therapy in Substance Treatment
A NA study, sponsored by Potomac Health Foundations.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT07108608 is a NA study that has completed, run by Potomac Health Foundations. The registered enrollment target is 26 participants.
The verdict
NCT07108608, a NA study, has completed, sponsored by Potomac Health Foundations.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this pilot non-randomized, uncontrolled clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) as adapted for use within the context of residential substance use disorder (SUD) treatment. All participants meet criteria for PTSD and are in a short term residential SUD treatment program (target residential treatment duration = 28 days) regardless of the research. The main question the study aims to answer is: 1) Is the delivery of adapted WET feasible and acceptable in short term residential SUD treatment for individuals with severe SUD?
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Written Exposure Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2026-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07108608
The ClinicalTrials.gov registry entry for NCT07108608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Potomac Health Foundations, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT07108608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07108608 about?
NCT07108608 is a clinical study titled "Adaptation of Written Exposure Therapy in Substance Treatment". The purpose of this pilot non-randomized, uncontrolled clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) as adapted for use within the context of residential substance use disorder (SUD) treatment. All participants meet ...
What is the current status of trial NCT07108608?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2025-11-21. Estimated completion is 2026-06-22.
What interventions are being tested in trial NCT07108608?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Written Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07108608?
This trial is sponsored by Potomac Health Foundations, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.